CRH
CRH's revenue rose 5.3% to $37.4 billion in fiscal 2025. Its operating margin was 14.5%, up from 13.8% a year earlier. Free cash flow was $2.9 billion, up 20.8%. It paid out $1.2 billion in dividends and buybacks, 41% of free cash flow. The diluted share count fell 1.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2018 to 2025, earnings per share fell 44.6% a year and net income grew 3.8% a year, while buybacks cut the share count by 19%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value CRH yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from CRH's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from CRH's fiscal 2025 free cash flow of $2.9B, net cash of −$14.1B at December 31, 2025 and 677 million diluted shares, from its filings. The scenarios are fitted to CRH: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 4.6% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11% for a cyclical or higher-risk business (Construction Materials); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $85.43
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from CRH's earnings per share of $5.67 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 17.7×, the middle of CRH's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 12%, 11% and 10%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $85.43
- Value at this multiple, against the last close
- —
- CRH's P/E at the last close
- 15.1×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Vulcan MaterialsVMC | $261.48 | $8.40 | 31.1× |
| Knife RiverKNF | $52.91 | $2.45 | 21.6× |
| CRHCRH | $85.43 | $5.67 | 15.1× |
| Eagle MaterialsEXP | $173.96 | $12.69 | 13.7× |
| Martin Marietta MaterialsMLM | $503.92 | $40.70 | 12.4× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 5.8 | 5.9 | 6.3 | 3.7 | 4.1 |
| Debt incl. finance leases | 10.5 | 9.7 | 11.8 | 14.2 | 18.2 |
| Net debt (negative means net cash) | 4.7 | 3.8 | 5.4 | 10.5 | 14.1 |
| Net debt to EBITDA | 1.0x | 0.7x | 0.9x | 1.6x | 1.9x |
| Debt to equity | 0.5x | 0.4x | 0.6x | 0.7x | 0.8x |
| Interest coverage | 10.6x | 11.1x | 11.1x | 8.1x | 6.7x |
| Current ratio | 1.9x | 1.8x | 1.7x | 1.4x | 1.7x |
| Quick ratio | 1.4x | 1.3x | 1.3x | 0.9x | 1.1x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $601,282 of CRH shares on the open market, and 1 insider sold $155,839.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 15, 2026 | Padraig ORiordainSee Remarks | Sold | 1,492 | $104.45 | $155,839 | Form 4 |
| Mar 12, 2026 | Siobhan TalbotDirector | Bought | 2,000 | $102.11 | $204,220 | Form 4 |
| Mar 11, 2026 | Richard H FearonDirector | Bought | 3,800 | $104.49 | $397,062 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | 6 of 9 | 6 of 9 | 7 of 9 |
| Accruals ratio | −4.0% | −3.0% | −3.4% |
Compare
Put CRH side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| CRH | FY25 | 5.3% | 14.5% | 7.8% | 11.8% | 1.9x | 7 | |
| Vulcan Materials | FY25 | 7.1% | 20.4% | 14.3% | 9.8% | 1.8x | 8 | Compare |
| Martin Marietta Materials | FY25 | 8.6% | 23.4% | 15.9% | 7.7% | 2.7x | 7 | Compare |
| Knife River | FY25 | 8.5% | 9.1% | −2.2% | 9.1% | 2.3x | 3 | Compare |
| Eagle Materials | FY26 | 2.1% | — | 8.6% | 16.3% | 2.0x | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | — | — | 27.4 | 28.1 | 25.9 | 29.2 | 32.7 | 34.9 | 35.6 | 37.4 |
| Revenue growth | — | — | — | 2.5% | −8.0% | 12.8% | 12.0% | 6.8% | 1.8% | 5.3% |
| Gross profit | — | — | 9.1 | 9.3 | 8.6 | 9.8 | 10.8 | 12.0 | 12.7 | 13.5 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | 2.4 | 2.8 | 2.0 | 3.3 | 3.8 | 4.2 | 4.9 | 5.4 |
| Net income | — | — | 2.9 | 1.7 | 1.1 | 2.6 | 3.9 | 3.2 | 3.5 | 3.8 |
| Diluted EPS (US$) | — | — | 344.70 | 2.13 | 1.42 | 3.32 | 5.11 | 4.33 | 5.02 | 5.51 |
| Diluted shares (millions) | 834 | 841 | 837 | 808 | 791 | 787 | 764 | 729 | 690 | 677 |
| Cash flow | ||||||||||
| Cash from operations | — | — | 2.2 | 3.9 | 3.9 | 4.0 | 3.8 | 5.0 | 5.0 | 5.6 |
| Capital expenditure | — | — | 1.3 | 1.4 | 1.0 | 1.6 | 1.5 | 1.8 | 2.6 | 2.7 |
| Free cash flow | — | — | 0.9 | 2.5 | 2.9 | 2.4 | 2.3 | 3.2 | 2.4 | 2.9 |
| Dividends paid | 0.0 | 0.0 | 0.6 | 0.7 | 0.7 | 0.9 | 0.9 | 0.0 | 0.0 | 0.0 |
| Share buybacks | 0.0 | 0.0 | 0.9 | 1.0 | 0.2 | 0.9 | 1.2 | 3.1 | 1.5 | 1.2 |
| Acquisitions | 0.0 | 0.0 | 4.1 | 0.7 | 0.4 | 1.5 | 3.3 | 0.6 | 4.9 | 3.9 |
| Stock-based compensation | — | — | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | — | — | 2.7 | 4.2 | 7.7 | 5.8 | 5.9 | 6.3 | 3.7 | 4.1 |
| Debt incl. finance leases | — | — | 17.2 | 15.8 | 12.2 | 10.5 | 9.7 | 11.8 | 14.2 | 18.2 |
| Total assets | — | — | 46.8 | 47.6 | 44.9 | 44.7 | 45.3 | 47.5 | 50.6 | 58.3 |
| Total liabilities | — | — | 27.8 | 28.0 | 24.6 | 23.8 | 22.3 | 25.8 | 27.8 | 32.9 |
| Shareholders' equity | — | 18.0 | 18.4 | 19.0 | 19.7 | 20.2 | 22.2 | 20.9 | 21.6 | 24.0 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | 33.0% | 33.0% | 33.1% | 33.6% | 33.0% | 34.2% | 35.7% | 36.1% |
| Operating margin | — | — | 8.9% | 9.9% | 7.8% | 11.4% | 11.6% | 12.0% | 13.8% | 14.5% |
| Net margin | — | — | 10.5% | 6.1% | 4.3% | 9.0% | 11.8% | 9.1% | 9.8% | 10.0% |
| Free cash flow margin | — | — | 3.4% | 8.9% | 11.4% | 8.3% | 7.0% | 9.2% | 6.8% | 7.8% |
| Return on capital | — | — | — | 6.5% | 5.0% | 10.3% | 11.3% | 12.1% | 12.7% | 11.8% |
| Return on equity | — | — | — | 9.2% | 5.8% | 13.2% | 18.2% | 14.8% | 16.4% | 16.5% |
| Return on assets | — | — | — | 3.6% | 2.4% | 5.9% | 8.6% | 6.8% | 7.1% | 6.9% |
| Net debt to EBITDA | — | — | — | — | 1.3x | 1.0x | 0.7x | 0.9x | 1.6x | 1.9x |